Abstract:Background & Objectives: Adipose-derived mesenchymal stem cells (ASCs) have been reported to improve acute lung injury in animal models. Mesenchymal stem cells have the capacity to regulate the function of macrophages. The goal of this study was to determine whether ASCs-educated macrophages could directly ameliorate acute lung injury in a mouse model. Materials & Methods: Mouse peritoneal macrophages were cocultured with ASCs in a Transwell system for 2 days to educate macrophages. Mice were divided into 5 groups: control, lipopolysaccharide (LPS), LPS + ASCs, LPS + untreated macrophages, and LPS + educated macrophages. Lung tissues, bronchoalveolar lavage and serum were harvested before and at 6, 24 and 48 h after LPS or saline treatment. For in vitro experiments, macrophages were cultured alone, cocultured directly with ASCs, or indirectly via Transwell for 48 h. Then, cells were incubated for 24 h with culture medium, medium + LPS, or medium + serum from patients with acute respiratory distress syndrome (ARDS). The expression of CD206+CD68+ M2 macrophages was analyzed via flow cytometry. The cell culture supernatants were collected for cytokine analysis. To determine the involvement of IL-10 in cytokine expression, macrophages were cocultured with ASCs in the presence of antibody for IL-10 or IL-10 receptor. Results: Educated macrophages decreased lung inflammation, reduced mouse weight loss and pulmonary edema, and ameliorated LPS-induced systemic inflammatory response. In vitro, ASCs increased expression of M2 macrophages independent of direct cell-to-cell contact when macrophages were treated with LPS or ARDS serum. Furthermore, ASCs alter the cytokine profile of macrophages induced by LPS through an IL-10-dependent mechanism. Conclusion: ASCs transform educated macrophages into a M2 phenotype which has immunomodulatory abilities and may have therapeutic potential in acute lung injury. Disclosure of Interest: None declared

Abstract PR566